Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine for routine pediatric vaccination programs in Japan

• Main Authors: Masayoshi Shinjoh (Author), Kanae Togo (Author), Tomoyuki Hayamizu (Author), Naohiro Yonemoto (Author), Junko Morii (Author), Johnna Perdrizet (Author), Kazumasa Kamei (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background The Japanese National Immunization Program currently includes the pediatric 13 valent pneumococcal conjugate vaccine (PCV13) to prevent pneumococcal infections. We aimed to evaluate the cost-effectiveness of 20-valent PCV (PCV20) as a pediatric vaccine versus PCV13.Methods A decision-anal...